Publications by authors named "Scott Carter"

Mutational processes, such as the molecular effects of carcinogenic agents or defective DNA repair mechanisms, are known to produce different mutation types with characteristic frequency profiles, referred to as mutational signatures. Non-negative matrix factorization (NMF) has successfully been used to discover many mutational signatures, yielding novel insights into cancer etiology and targeted therapies. However, the NMF model is only a rough approximation to reality, and even small departures from this assumed model can have large negative effects on the accuracy and reliability of the results.

View Article and Find Full Text PDF

The heterogeneity of outcomes in behavioral research has long been perceived as a challenge for the validity of various theoretical models. More recently, however, researchers have started perceiving heterogeneity as something that needs to be not only acknowledged but also actively addressed, particularly in applied research. A serious challenge, however, is that classical psychological methods are not well suited for making practical recommendations when heterogeneous outcomes are expected.

View Article and Find Full Text PDF

Objective: The purpose of this study was to enhance the current knowledge of the relationship between the gut microbiome and osteoarthritis (OA) and associated pain using pet dogs as a clinically relevant translational model.

Methods: Fecal samples were collected from 93 owned pet dogs. Dogs were designated as either clinically healthy or OA pain using validated methods.

View Article and Find Full Text PDF

Introduction And Hypothesis: Pelvic floor myofascial pain (PFMP) is a common but underrecognized component of chronic pelvic pain and pelvic floor disorders symptoms with limited, well-studied treatment modalities. Our objective was to determine the effect of vaginal cryotherapy on PFMP with palpation.

Methods: Following a standardized PFMP screening examination, individuals with a pain score ≥4/10 in ≥1 of four muscle groups were invited to participate in a randomized controlled trial comparing patients undergoing vaginal cryotherapy with controls.

View Article and Find Full Text PDF

Individuals differ markedly in how they experience the ebb and flow of emotions. In this study, we used daily experience sampling to examine whether these differences reflect the nature and presence of mood disorders or whether they can better be characterized as distinct dynamic emotion profiles that cut-across diagnostic boundaries. We followed 105 individuals in 2019-2020 with diagnoses of major depression, remitted major depression, bipolar disorder, or no history of disorder, over 14 days ( = 6,543 experience-sampling assessments).

View Article and Find Full Text PDF

Purpose: Preclinical data showed that prophylactic, low-dose temozolomide (TMZ) significantly prevented breast cancer brain metastasis. We present results of a phase I trial combining T-DM1 with TMZ for the prevention of additional brain metastases after previous occurrence and local treatment in patients with HER2+ breast cancer.

Patients And Methods: Eligible patients had HER2+ breast cancer with brain metastases and were within 12 weeks of whole brain radiation therapy (WBRT), stereotactic radiosurgery, and/or surgery.

View Article and Find Full Text PDF

Physician explicit and implicit biases involving race and sexual orientation (SO) affect patient and provider experiences in healthcare settings. An anonymous survey was disseminated nationally to graduating medical students, residents, and practicing physicians to evaluate SO and racial biases across medical specialties. SO explicit and implicit bias were measured with the Attitudes toward Lesbians and Gay Men Scale, short form (ATLG-S) and Gay-Straight Implicit Association Test (IAT).

View Article and Find Full Text PDF

Motivation: Somatic copy-number alterations (SCNAs) play an important role in cancer development. Systematic noise in sequencing and array data present a significant challenge to the inference of SCNAs for cancer genome analyses. As part of The Cancer Genome Atlas, the Broad Institute Genome Characterization Center developed the Tangent normalization method to generate copy-number profiles using data from single-nucleotide polymorphism (SNP) arrays and whole-exome sequencing (WES) technologies for over 10 000 pairs of tumors and matched normal samples.

View Article and Find Full Text PDF

Melanoma-derived brain metastases (MBM) represent an unmet clinical need because central nervous system progression is frequently an end stage of the disease. Immune checkpoint inhibitors (ICI) provide a clinical opportunity against MBM; however, the MBM tumor microenvironment (TME) has not been fully elucidated in the context of ICI. To dissect unique elements of the MBM TME and correlates of MBM response to ICI, we collected 32 fresh MBM and performed single-cell RNA sequencing of the MBM TME and T-cell receptor clonotyping on T cells from MBM and matched blood and extracranial lesions.

View Article and Find Full Text PDF

Hypospadias is a common form of congenital atypical sex development that is often associated with other congenital comorbidities. Many genes have been associated with the condition, most commonly single sequence variations. Further investigations of recurrent and overlapping copy number variations (CNVs) have resulted in the identification of genes and chromosome regions associated with various conditions, including differences of sex development (DSD).

View Article and Find Full Text PDF

Importance: Understanding women's acceptance of telemedicine as a model of care for pelvic floor disorders (PFDs) allows for a more patient-centered approach to widespread implementation in female pelvic medicine and reconstructive surgery.

Objectives: The pandemic sparked rapid and widespread implementation of telemedicine. Our goal was to assess acceptance, satisfaction, and desire for future use of telemedicine among women seeking care for PFDs.

View Article and Find Full Text PDF

Motivation: Cross-sectional analyses of primary cancer genomes have identified regions of recurrent somatic copy-number alteration, many of which result from positive selection during cancer formation and contain driver genes. However, no effective approach exists for identifying genomic loci under significantly different degrees of selection in cancers of different subtypes, anatomic sites or disease stages.

Results: CNGPLD is a new tool for performing case-control somatic copy-number analysis that facilitates the discovery of differentially amplified or deleted copy-number aberrations in a case group of cancer compared with a control group of cancer.

View Article and Find Full Text PDF
Article Synopsis
  • Recent studies indicate that the cyclin-dependent kinase (CDK) pathway could be a promising target for treating brain metastases (BM).
  • The interim analysis of a trial shows that the CDK inhibitor palbociclib is effective for patients with progressive BM that have CDK alterations.
  • The findings support the importance of molecular testing on archived BM tissue to help choose targeted therapies that can penetrate the central nervous system (CNS).
View Article and Find Full Text PDF
Article Synopsis
  • Leptomeningeal disease (LMD) is a serious complication in solid tumors, showing a poor prognosis and limited treatment options.
  • A Phase II study involving 18 patients tested the combined treatment of ipilimumab and nivolumab, with promising results: 44% of patients were alive at three months, surpassing the expected 18%.
  • While some patients experienced severe side effects, the overall safety profile was acceptable, indicating the need for larger studies to further assess the treatment's effectiveness.
View Article and Find Full Text PDF
Article Synopsis
  • * We conducted two clinical trials to study the effectiveness of immune checkpoint inhibitors (ICI) in treating LMD and analyzed patient samples using advanced techniques like single-cell RNA sequencing.
  • * Our research reveals important insights into the tumor environment in LMD and demonstrates the potential of using genomic profiling to enhance understanding and treatment strategies for this condition.
View Article and Find Full Text PDF
Article Synopsis
  • Leptomeningeal disease (LMD) is a severe cancer complication often missed due to the low accuracy of current diagnostic methods like CSF cytology.
  • This study aimed to evaluate if analyzing cell-free DNA (cfDNA) in CSF could provide a more reliable diagnosis for LMD compared to traditional cytologic methods.
  • In a cohort of 30 patients, cfDNA analysis identified LMD correctly in 94% of follow-up samples, significantly outperforming cytologic analysis, indicating a potential improvement in diagnosing LMD.
View Article and Find Full Text PDF

To understand the mechanisms that mediate germline genetic leukemia predisposition, we studied the inherited ribosomopathy Shwachman-Diamond syndrome (SDS), a bone marrow failure disorder with high risk of myeloid malignancies at an early age. To define the mechanistic basis of clonal hematopoiesis in SDS, we investigate somatic mutations acquired by patients with SDS followed longitudinally. Here we report that multiple independent somatic hematopoietic clones arise early in life, most commonly harboring heterozygous mutations in EIF6 or TP53.

View Article and Find Full Text PDF

Feeding pigs with very-low protein (VLP) diets while supplemented with limiting amino acids (AA) results in decreased growth. The objective of this study was to determine if supplementing VLP diets with branched-chain AA (BCAA) would reverse the negative effects of these diets on growth and whether this is associated with alterations in energy balance, blood metabolomics and fecal microbiota composition. Twenty-four nursery pigs were weight-matched, individually housed and allotted into following treatments (n = 8/group): control (CON), low protein (LP) and LP supplemented with BCAA (LP + BCAA) for 4 weeks.

View Article and Find Full Text PDF
Article Synopsis
  • An amendment to the original paper has been released.
  • This updated information can be found through a link provided at the beginning of the paper.
  • Readers should check the link for the latest changes or additions to the research.
View Article and Find Full Text PDF
Article Synopsis
  • An increasing number of metastatic cancer patients suffer from leptomeningeal dissemination (LMD), leading to poor survival rates; researchers conducted a phase 2 study of pembrolizumab to assess its effectiveness in these patients.
  • The study included 20 patients with solid tumors (mostly breast cancer), who received pembrolizumab every 3 weeks, and the main goal was to evaluate overall survival at 3 months.
  • The results showed that 60% of patients were alive at 3 months, with some side effects reported, suggesting pembrolizumab is safe and potentially beneficial for LMD, though more research is needed to pinpoint which patients may benefit the most.
View Article and Find Full Text PDF

The molecular mechanisms leading to resistance to PD-1 blockade are largely unknown. Here, we characterize tumor biopsies from a patient with melanoma who displayed heterogeneous responses to anti-PD-1 therapy. We observe that a resistant tumor exhibited a loss-of-function mutation in the tumor suppressor gene , whereas a sensitive tumor from the same patient did not.

View Article and Find Full Text PDF

Brain metastases occur in up to 25-55% of patients with metastatic HER2-positive breast cancer. Standard treatment has high rates of recurrence or progression, limiting survival and quality of life in most patients. Temozolomide (TMZ) is known to penetrate the blood-brain barrier and is US FDA approved for treatment of glioblastoma.

View Article and Find Full Text PDF
Article Synopsis
  • Brain metastases from lung adenocarcinoma (BM-LUAD) are a major cause of death, prompting research into genetic factors that support their development.
  • Whole-exome sequencing of 73 BM-LUAD cases revealed candidate genes with significant changes compared to primary lung adenocarcinoma, with highlights on MYC, YAP1, and MMP13 having higher amplification rates.
  • Functional tests in mouse models showed that overexpressing MYC, YAP1, or MMP13 increased brain metastasis, indicating that genetic alterations play a key role in the progression of these tumors.
View Article and Find Full Text PDF